IMDXInsight Molecular Diagnostics Inc.
6.300USD-0.32%Mkt Cap: 203.43M USDP/E: Last update: 2026-06-01

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests,…

Indicators:|

Key Statistics

Company
Market Cap203.43M USD
Enterprise Value175.36M USD
Revenue (TTM)1.95M USD
Gross Profit2.30M USD
Net Income (TTM)-50.22M USD
Revenue/Share0.0600 USD
Last Price6.300 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees55
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-7.96
PEG
EV/EBITDA-5.38
EV/Revenue89.98
P/S102.88
P/B-18.76
EPS (TTM)-1.51
EPS (Forward)-0.78
52W Range
2.33064% of range8.510
52W High8.510 USD
52W Low2.330 USD
Profitability
Gross Margin56.67%
Oper. Margin-32284.38%
EBITDA Margin0.00%
Profit Margin-1238.52%
ROE159.62%
ROA-194.99%
Growth
Revenue Growth-98.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-22.18M USD
CapEx (TTM)3.19M USD
FCF Margin-809.11%
FCF Yield-7.75%
Net Debt-25.13M USD
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity-0.11
Current Ratio2.54
Quick Ratio2.36
Book Value/Sh-0.3310 USD
Cash/Share0.8730 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:20
Split DateJul 25, 2023
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)8.333 USD
Target Range4.000 USD12.00 USD
# Analysts3
Ownership
Shares Out.32.29M
Float10.08M
Insiders20.02%
Institutions61.45%
Short Interest
Short Ratio2.5d
Short % Float7.47%
Short % Out.3.66%
Shares Short1.18M
Short (prev mo.)455.87K
Technical
SMA 504.389 (+43.5%)
SMA 2004.978 (+26.6%)
Beta
S&P 52W Chg27.94%
Avg Vol (30d)416.67K
Avg Vol (10d)434.32K
Technical Indicators
RSI (14)59.9
MACD0.5641
MACD Signal0.5253
MACD Hist.+0.0388
BB Upper7.102 USD
BB Middle5.618 USD
BB Lower4.134 USD
BB Width52.83%
ATR (14)0.6624 USD
Vol Ratio (20d)0.45x